National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
   
 
Results: 1 -4 of 4         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Pharmaceutical / Industry


BrTK02
5R44CA107745, NCT00589875

First Published: 8/5/2008  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Approved-not yet active


3 to 17


Other, Pharmaceutical / Industry


DFCI-07098
07-098, ADVANTAGENE-DFCI-07098, NCT00729105


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


PaTK01
1R43CA119847, NCT00638612


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


BrTK01
5R44CA107745, NCT00751270

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov